Seeking Alpha

cmcfarling

cmcfarling
Send Message
View as an RSS Feed
View cmcfarling's Comments BY TICKER:
Latest  |  Highest rated
  • InVivo's Day Has Arrived [View article]
    Don't forget, from 3/17...

    "The Company also announced that, as a result of ongoing discussions with clinical experts, we are reviewing non-traumatic spinal cord impairment indications that could benefit from our device. This effort could result in additional uses of the scaffold and may expand the entire development program."

    If they determine that the device is safe, there could many uses for the technology. The thought process is this...

    Human trials must be done initially with scaffold alone to prove safety. That leaves the option to conduct trials an acute SCI or chronic SCI patients. In either case the results in regard to safety would likely be the same. So pick the one that also the most chance to show improvement to the injury. Acute SCI wins.
    May 1 03:05 PM | 1 Like Like |Link to Comment
  • InVivo's Day Has Arrived [View article]
    If you have been injured and will likely be a 6 on the BBB scale, what would you do to get to an 8 or 9? Would you let a surgeon implant a small sponge-like device in your spinal cord that will dissolve in a few weeks that MAY make your condition better? I think I would. Anything closer to full functionality has to be better even if it's a couple of steps on the scale. That may mean 10%, 20%, 30% less that you have to rely on someone else for the rest of your life to help you with comman day-to-day activities. It may turn out that the scaffold alone does nothing for you, but so what, that's where you were anyway.

    The improvements with the scaffold alone in the animal studies cannot simply be ignored or discounted. If the human scaffold does nothing this trial is a success because this trial is intended just to determine safety. If improvements are shown (which I believe will happen) then that is icing on the cake. Of course if the patients are determined to be worse off then NVIV is worth $0. That scenario is extremely unlikely. Again the animal data can't be ignored and there are some very smart people who have spent enormous amounts of time pondering if this will work.

    5% chance that scaffold is harmful
    35% chance it does nothing
    60% chance it improves the condition
    May 1 02:21 PM | 3 Likes Like |Link to Comment
  • InVivo's Day Has Arrived [View article]
    No mention of hydrogel. Curious what Perrin had to say about that.
    Apr 30 08:17 AM | 1 Like Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    "If it turns out that there is nothing rotten in the state of Growlife" then there's no reason to bash Brochstein. You're jumping the gun a bit don't you think?
    Apr 15 09:23 AM | 3 Likes Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    Yes and Brochstein has been cautioning of the FSPM share structure for months.
    Apr 15 09:20 AM | Likes Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    Yes, the buyers of NFLX at $458 can hold their head high knowing that they have lost 28% of their investment on a well vetted company. LOL.

    No basis for investment decisions? Come on. There is news and filings constantly, just like any exchange traded stock. Your argument is against the OTC in general. You can either embrace the OTC for what it is and invest accordingly or simply stay away and stick to perceived "safer" investments.
    Apr 15 09:18 AM | 6 Likes Like |Link to Comment
  • Cannabis Stocks: What The Growlife Halt Means For The Industry [View article]
    The irony is that the SEC is hurting investors more than if they had done nothing. So what if the valuations are high. Everyone knows that and if you don't it's your own fault. What's worse, buying PHOT at $.78 or NFLX at $458? Not much difference really.
    Apr 15 03:02 AM | 25 Likes Like |Link to Comment
  • Growlife: Taking A Page From Amazon [View article]
    Hence the recent vote to raise the A/S to 3 billion.
    Apr 2 01:40 AM | 1 Like Like |Link to Comment
  • Nokia: Yes To QWERTY Nokia X And Lumia Phones [View article]
    I hate on-screen keyboards for anything other than a short message. As a sys admin I also hate trying to walk users through configuring things on their phone remotely. A slide out QWERTY phone is a no brainer IMO, you get the best of both worlds. So what if it's slightly thicker. IF MS would build remote access into the Windows Phone OS then phones could managed remotely just like PCs. The combination of the two would make for a huge advantage in the corporate market.
    Mar 30 01:18 AM | 2 Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    I looked into SING. It doesn't look like there's much there there. Their technology is like a poor man's Google wallet. Anyone who would use their software would be better off just using a credit card swiping terminal.
    Mar 17 10:34 PM | Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    The same advertising that PHOT used last year. Was that gratuitous?
    Mar 16 12:35 PM | Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    Don't forget the pumped up GNC orders for FITX, complete with pics on their Facebook page, that ended up not happening because "Bill decided" (cough) to not go with them.
    Mar 16 12:29 PM | Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    Software for tracking seed-to-sale could be as simple as an Excel spreadsheet. I'm not sure how sophisticated such a system has to be and I suspect most won't be overly sophisticated. There are app developers that could probably write a smartphone app for this in a week.

    What's the revenue potential of EDXC? Pretty minimal I think. Say their software costs $10,000, which is probably way higher than it really should. Even with 100 grow ops using it that's only $1,000,000 in revenue. And they only get that one time. They may have ongoing maintenance contracts but the cost would be substantially lower for those. And the end users may not choose to renew them anyway. It seems the potentially is greatly lacking here.
    Mar 14 05:12 PM | 3 Likes Like |Link to Comment
  • Marijuana Stocks: This Year, April 1 Will Be The New 4/20 [View article]
    I was a big PHOT fan since early 2013. The FITX deal tuned me bearish against them. As you pointed out, there are much better approaches to getting into the Canadian market.

    Tweed won't be trading in the U.S., at least initially, so that will leave it out of reach for a significant portion of the mj investor community. Sure you can set up a separate broker account that allows international trading but how many will go through the hassle? Unless you're in on the IPO the potential gains will be minimal I think anyway. That leaves ENRT who, by the way, may very well be the first publicly traded company to sell cannabis. You mentioned that Tweed will be the first, as if it's a foregone conclusion. WOM is ready to go and is just waiting to hear from Health Canada. They could certainly be ready before April 1.

    There are concerns about every one of these companies right now. It seems to me though that ENRT is still under the radar and at a valuation that, if things go well, can provide for substantial returns. I could see ENRT playing out similarly to FSPM. Not too long ago it was at $.25.
    Mar 14 04:50 PM | 3 Likes Like |Link to Comment
  • Canadian Marijuana Market And The Prospectors [View article]
    The address is

    9701 - 201st Langley B.C.
    V1M 3E7

    It's on the forms that users must fill out, I'm not sure why it's not on the website directly.

    Also, a little more info on the people at WOM...
    http://bit.ly/1noK3Bw
    Mar 14 02:30 AM | Likes Like |Link to Comment
COMMENTS STATS
75 Comments
170 Likes